These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of chemotaxis during Campylobacter jejuni colonisation and pathogenesis. Korolik V Curr Opin Microbiol; 2019 Feb; 47():32-37. PubMed ID: 30476739 [TBL] [Abstract][Full Text] [Related]
5. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Dasti JI; Tareen AM; Lugert R; Zautner AE; Gross U Int J Med Microbiol; 2010 Apr; 300(4):205-11. PubMed ID: 19665925 [TBL] [Abstract][Full Text] [Related]
9. Chronic effects of Campylobacter infection. Nachamkin I Microbes Infect; 2002 Apr; 4(4):399-403. PubMed ID: 11932190 [TBL] [Abstract][Full Text] [Related]
10. Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? O Cróinín T; Backert S Front Cell Infect Microbiol; 2012; 2():25. PubMed ID: 22919617 [TBL] [Abstract][Full Text] [Related]
11. Role of putative virulence traits of Campylobacter jejuni in regulating differential host immune responses. Singh A; Mallick AI J Microbiol; 2019 Apr; 57(4):298-309. PubMed ID: 30796746 [TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni: components for adherence to and invasion of eukaryotic cells. Lugert R; Gross U; Zautner AE Berl Munch Tierarztl Wochenschr; 2015; 128(3-4):90-7. PubMed ID: 25876267 [TBL] [Abstract][Full Text] [Related]
13. Revisiting Elmi A; Nasher F; Dorrell N; Wren B; Gundogdu O Front Cell Infect Microbiol; 2020; 10():607704. PubMed ID: 33614526 [No Abstract] [Full Text] [Related]
14. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen. Day CJ; Semchenko EA; Korolik V Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of the virulence potential of Campylobacter jejuni strains by use of gene transcription analysis and a Caco-2 assay. Poli VF; Thorsen L; Olesen I; Wik MT; Jespersen L Int J Food Microbiol; 2012 Apr; 155(1-2):60-8. PubMed ID: 22336513 [TBL] [Abstract][Full Text] [Related]
16. Cellular Tight Junctions Prevent Effective Hatayama S; Shimohata T; Amano S; Kido J; Nguyen AQ; Sato Y; Kanda Y; Tentaku A; Fukushima S; Nakahashi M; Uebanso T; Mawatari K; Takahashi A Front Cell Infect Microbiol; 2018; 8():15. PubMed ID: 29441328 [No Abstract] [Full Text] [Related]
17. How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis. Szymanski CM; Gaynor EC Gut Microbes; 2012; 3(2):135-44. PubMed ID: 22555465 [TBL] [Abstract][Full Text] [Related]
18. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Louwen R; Horst-Kreft D; de Boer AG; van der Graaf L; de Knegt G; Hamersma M; Heikema AP; Timms AR; Jacobs BC; Wagenaar JA; Endtz HP; van der Oost J; Wells JM; Nieuwenhuis EE; van Vliet AH; Willemsen PT; van Baarlen P; van Belkum A Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):207-26. PubMed ID: 22945471 [TBL] [Abstract][Full Text] [Related]
19. Status of vaccine research and development for Campylobacter jejuni. Riddle MS; Guerry P Vaccine; 2016 Jun; 34(26):2903-2906. PubMed ID: 26973064 [TBL] [Abstract][Full Text] [Related]
20. The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease. Samuelson DR; Eucker TP; Bell JA; Dybas L; Mansfield LS; Konkel ME Cell Commun Signal; 2013 Oct; 11():79. PubMed ID: 24144181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]